In GCB-DLBCL patients with IPI scores >2, p63+ GCB-DLBCL patients showed trends of better OS and PFS (P=0.078 and P=0.057 respectively) (Fig 3i-j). This evidence concerns the gene TP63 and diffuse large B-cell lymphoma.